trial · primary record
Lumateperone
Depressive Disorder, Major
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 585 |
| Primary completion | 2029-10-23 |
| Primary endpoint | Change from DB Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score to End of Week 6 |
| Registry ID | NCT07747389 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:46.896Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07747389
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Lumateperone · compound